The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. The metric has seen a significant loss of -41.46% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -53.51%. Over the past 30 days, the price of ATRA has leaped by -32.87%. And in the last five days, it has fallen by -6.80%.
The current stock price for Atara Biotherapeutics Inc. (ATRA) is $1.92. The stock experienced a significant increase during the last trading session, reaching $2.08 after opening at $2.08. It dipped to a low of $1.86 before ultimately closing at $2.08.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
Sponsored
Atara Biotherapeutics Inc. had a pretty Dodgy run when it comes to the market performance. Over the past year, the company’s stock reached a high of $9.34 on 07/06/22, while the lowest price during the same period was $1.94 on 05/24/23.
52-week price history of ATRA Stock
The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. Atara Biotherapeutics Inc.’s current trading price is -79.44% away from its 52-week high, while its distance from the 52-week low is -1.03%. The stock’s price range for this period has been between $1.94 and $9.34. The Healthcare sector company’s shares saw a trading volume of about 2.17 million for the day, which was higher than the average daily volume of 1.45 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Atara Biotherapeutics Inc. (ATRA) has experienced a quarterly decline of -55.04% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 181.90M and boasts a workforce of 330 employees.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 3.40, with a change in price of -1.22. Similarly, Atara Biotherapeutics Inc. recorded 1,301,306 in trading volume during the last 100 days, posting a change of -38.85%.
ATRA’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for ATRA stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.00.
ATRA Stock Stochastic Average
As of today, the raw stochastic average of Atara Biotherapeutics Inc. over the last 50 days is at 4.58%. This shows a declinee from the raw stochastic average of the previous 20 days, which was recorded at 5.19%. Further, the company’s Stochastic %K and %D values for the last 20 days were 11.03% and 12.94%, respectively.
